For people 12 years of age & older to
HELP PROTECT AGAINST
COVID-19 AND SEVERE
ILLNESS TOO*
The vaccine may not protect everyone.
*Given as a 2-dose primary series, 3 weeks apart.
For people 12 years of age & older to
Help protect against COVID-19 and severe illness too*
The vaccine may not protect everyone.
*Given as a 2-dose primary series, 3 weeks apart.
The most widely used COVID-19 vaccine in the U.S.†
†CDC data for Pfizer and BioNTech as of 8/19/2022.
Primary Series for 12 years of Age & Older
1st
Dose
2nd
Dose
3rd
Dose
21 days
28 days
FDA APPROVED
The vaccine is administered as a primary series of 2 doses that are given 3 weeks apart.
FDA AUTHORIZED
For individuals with certain kinds of immunocompromise, a third primary series dose may be administered at least 28 days after the second dose.
For ages 12 years and older, the vaccine comes in a vial with a gray cap
There are no data available on the interchangeability of COMIRNATY with
FIND A VACCINE
APPOINTMENT
NEAR YOU
Take the next step toward helping to protect against
YOUR QUESTIONS ABOUT THE VACCINE —- ANSWERED
If you’re considering the vaccine for yourself or your child 12 years of age and
older,
the information below can help you get started.
Recently Added
COMIRNATY is produced under the supervision of the Islamic Food and Nutrition Council of America (IFANCA). The vaccine is manufactured and packed on clean equipment using validated cleaning, and the materials used to manufacture the vaccine have been reviewed and approved to meet the halal guidelines.
Additional Questions
You should contact your healthcare or vaccine provider or the location where you received your first dose to discuss the appropriate timing of your second primary series dose.
FDA-Approved Vaccination Schedule
The FDA-approved interval between the first and second dose has not changed and is as follows:
- COMIRNATY® (
COVID-19 Vaccine, mRNA) is FDA approved in people 12 years of age and older to be administered as a 2-dose primary series given 3 weeks apart
Select CDC Considerations for Intervals for mRNA
The CDC updated its
- The CDC continues to recommend a 3-week interval between the first and second dose of the vaccine for people who are moderately or severely immunocompromised and adults ages 65 years and older
Your healthcare or vaccination provider will help you decide the timing of the second primary series dose that is right for you.
Tell the vaccination provider about all of your medical conditions, including
if you:
- have any allergies
- have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)
- have a fever
- have a bleeding disorder or are on a blood thinner
- are immunocompromised or are on a medicine that affects your immune system
- are pregnant or plan to become pregnant
- are breastfeeding
- have received another
COVID-19 vaccine - have ever fainted in association with an injection
